Gainers
- Calliditas Therapeutics CALT shares increased by 50.56% to $28.23 during Wednesday's after-market session. This security traded at a volume of 202.8K shares come close, making up 482.16% of its average volume over the last 100 days. The market value of their outstanding shares is at $738.8 million.
- Checkmate Pharmaceuticals CMPI shares increased by 6.51% to $3.27. The market value of their outstanding shares is at $70.7 million.
- Pasithea Therapeutics KTTA stock moved upwards by 5.58% to $2.08. The company's market cap stands at $45.5 million.
- PolarityTE PTE shares moved upwards by 4.74% to $0.42. The company's market cap stands at $34.3 million.
- Unity Biotechnology UBX shares rose 4.54% to $1.84. Today's trading volume for this security ended up closing at 99.8K shares, which is 11.9 percent of its average volume over the last 100 days. The company's market cap stands at $106.2 million.
- Sharecare SHCR stock increased by 4.52% to $5.08. The market value of their outstanding shares is at $1.7 billion.
Losers
- InVivo Therapeutics Hldg NVIV shares declined by 9.72% to $0.54 during Wednesday's after-market session. This security traded at a volume of 231.5K shares come close, making up 33.65% of its average volume over the last 100 days. The market value of their outstanding shares is at $18.5 million.
- Verrica Pharmaceuticals VRCA stock decreased by 9.67% to $8.51. The company's market cap stands at $234.1 million.
- Onconova Therapeutics ONTX stock declined by 7.86% to $2.58. The market value of their outstanding shares is at $53.8 million.
- Allena Pharmaceuticals ALNA stock decreased by 6.47% to $0.65. The market value of their outstanding shares is at $53.6 million.
- Cue Health HLTH stock fell 5.8% to $10.24. The company's market cap stands at $1.4 billion.
- Fortress Biotech FBIO shares decreased by 4.95% to $2.5. Fortress Biotech's trading volume hit 85.1K shares by close, accounting for 14.01% of its average volume over the last 100 days. The market value of their outstanding shares is at $249.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in